Zdrowie i gospodarka · 09/05/2013

FDA Releases Draft Guidance on Expanded Access to Investigational Drugs for Treatment Use

The Food and Drug Administration (FDA) has published a draft guidance document to address frequently asked questions about its expanded access regulations for investigational drugs used for treatment purposes, aiming to provide clarity for industry, researchers, physicians, and patients.